The continued emergence of new SARS‐CoV‐2 variants has accentuated the growing need for fast and reliable methods for the design of potentially neutralizing antibodies (Abs) to counter immune evasion by the virus. Here, we report on the de novo computational design of high affinity antibody variable regions (Fv) through the recombination of VDJ genes targeting the most solvent‐exposed hACE2‐binding residues of the SARS‐CoV‐2 spike receptor binding domain (RBD) protein using the software tool OptMAVEn‐2.0. 2 Subsequently, we carried out computational affinity maturation of the designed variable regions through amino‐acid substitutions for improved binding with the target epitope. Immunogenicity of designs was restricted by preferring designs that match sequences from a 9‐mer library of “human antibodies” based on human string content score 74 . We generated 106 different designs and reported in detail on the top five that trade‐off the greatest computational binding affinity for the RBD with human string content scores. We further describe computational evaluation of the top five designs produced by OptMAVEn‐2.0 1 using a Rosetta‐based approach. We used Rosetta SnugDock 2,3 for local docking of the designs to evaluate their potential to bind the spike RBD and performed “forward folding” with DeepAb 4 to assess their potential to fold into the designed structures. Ultimately, our results identified one designed antibody variable region, P1.D1, as a particularly promising candidate for experimental testing. This effort puts forth a computational workflow for the de novo design and evaluation of antibodies that can quickly be adapted to target spike epitopes of emerging SARS‐CoV‐2 variants or other antigenic targets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.